Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Adie
Viljoen
MBChB FCP(SA) MMed FRCPath MBA, Lister Hospital & Cambridge Universities NHS Trust, UK

Dr Adie Viljoen is a clinical specialist and works as a Consultant Chemical Pathologist and Metabolic Physician in Hertfordshire, UK, having trained in South Africa where he received his medical and specialty medicine qualifications.  He conducts clinics in diabetes, cardiovascular risk prevention, lipid and metabolic disorders and his interests include type 2 diabetes and diabetic dyslipidaemia, diabetes.

 

He is a Senior Lecturer in Medicine at the Bedfordshire and Hertfordshire Postgraduate Medical, and a Member of the Institute for Diabetes in Older People (IDOP). He is the UK Chief Investigator and Principal Site investigator for several international phase 2 and 3 research trials in diabetes, obesity and lipids including studies such as EXAMINE, ORIGIN, 4T, CRESCENDO. He is a member of the Scientific Research Committee of HEART UK and the UK cholesterol charity.